Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions.

Area of Science:

• Obstetrics and Gynecology
• Sexual Health
• Women's Health

Background:

• Female sexual dysfunction (FSD) is common, affecting 20-40% of women and causing personal distress.
• FSD encompasses several conditions: female sexual interest and arousal disorder, female orgasmic disorder, genitopelvic pain and penetration disorder, and substance/medication-induced sexual dysfunction.
• Obstetrician-gynecologists play a key role in identifying risk factors and screening for FSD.

Purpose of the Study:

• To highlight the prevalence and types of female sexual dysfunction.
• To emphasize the importance of screening for FSD in clinical practice.
• To outline current treatment approaches for different types of FSD.

Main Methods:

• Review of current literature and clinical guidelines on female sexual dysfunction.
• Discussion of diagnostic criteria and screening protocols for FSD.
• Summary of evidence-based treatment strategies for various FSD subtypes.

Main Results:

• FSD is a prevalent condition with significant personal impact.
• Effective treatments are available, including cognitive behavioral therapy, mindfulness, pharmaceutical management, education, and addressing underlying etiologies.
• Substance- or medication-induced FSD requires cessation of the offending agent and potential adjunctive therapies.

Conclusions:

• Female sexual dysfunction is often underdiagnosed and undertreated.
• Comprehensive screening and individualized treatment plans are essential for managing FSD.
• Integrated medical and psychological approaches offer effective management options for women experiencing sexual dysfunction.